These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6385266)

  • 1. Clinical safety and tolerance of mitoxantrone.
    Crossley RJ
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):54-8. PubMed ID: 6385266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone: an overview of safety and toxicity.
    Posner LE; Dukart G; Goldberg J; Bernstein T; Cartwright K
    Invest New Drugs; 1985; 3(2):123-32. PubMed ID: 3894276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line mitoxantrone chemotherapy for advanced breast cancer.
    Wilson KS; Paterson AH
    Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
    Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J
    Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
    Stewart DJ; Maroun JA; Hirte W; Perrault D; Stolbach L; Cripps C; Lefebvre B
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):23-7. PubMed ID: 6385261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Moore JO; Olsen GA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
    Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB
    Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.
    Allegra JC; Woodcock T; Woolf S; Henderson IC; Bryan S; Reisman A; Dukart G
    Invest New Drugs; 1985; 3(2):153-61. PubMed ID: 3894278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone in malignant lymphoma.
    Gams RA; Steinberg J; Posner L
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):47-9. PubMed ID: 6484580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
    Holmes FA; Yap HY; Esparza L; Buzdar AU; Hortobagyi GN; Blumenschein GR
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):28-31. PubMed ID: 6385262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.
    Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT; Smyth JF
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1141-6. PubMed ID: 6541135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
    McDonald DB; Abu-Zahra H; Yoshida S; Binder H
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer.
    Ford JM; Panasci L; Leclerc Y; Margolese R
    Cancer Treat Rep; 1987 Oct; 71(10):921-5. PubMed ID: 3308079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer.
    Neidhart JA; Gochnour D; Roach RW; Young D; Steinberg JA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):11-4. PubMed ID: 6385259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
    Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
    Coleman RE; Maisey MN; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.